Cogent Biosciences, Inc.
COGT
$12.23
$0.443.73%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -3.18% | -14.43% | -14.44% | -7.63% | -16.64% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -0.87% | -23.12% | 56.35% | -11.04% | 9.61% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -3.11% | -14.70% | -13.19% | -7.69% | -16.28% |
|
|||||
Total Current Assets | -3.11% | -14.70% | -13.19% | -7.69% | -16.28% |
Net Property, Plant & Equipment | -4.24% | -1.93% | -3.74% | -2.88% | -3.18% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Assets | -3.16% | -13.45% | -14.61% | -10.68% | -9.70% |
|
|||||
Total Accounts Payable | 17.46% | 17.82% | -20.24% | 67.81% | -42.34% |
Total Accrued Expenses | 17.53% | -60.58% | 131.99% | 23.41% | 53.79% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.92% | 2.94% | 2.96% | 3.05% | 3.00% |
Total Finance Division Other Current Liabilities | 163.02% | 29.76% | 21.90% | 21.43% | -60.38% |
Total Other Current Liabilities | 163.02% | 29.76% | 21.90% | 21.43% | -60.38% |
Total Current Liabilities | 18.46% | -11.47% | 5.02% | 32.61% | 9.04% |
|
|||||
Total Current Liabilities | 18.46% | -11.47% | 5.02% | 32.61% | 9.04% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -2.77% | -2.65% | -2.50% | -2.39% | -2.24% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 47,080.00% | -- | -- | -- | -- |
Total Liabilities | 84.84% | -9.51% | 3.25% | 22.30% | 5.46% |
|
|||||
Common Stock & APIC | 0.96% | 3.72% | 1.01% | 1.48% | 13.69% |
Retained Earnings | -7.89% | -8.38% | -8.58% | -9.80% | -8.91% |
Treasury Stock & Other | -92.07% | -63.31% | -50.11% | 566.67% | -392.31% |
Total Common Equity | -57.48% | -23.93% | -28.61% | -21.24% | 29.43% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -0.23% | -2.20% | 0.00% | -3.08% | -48.63% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -0.23% | -2.20% | 0.00% | -3.08% | -48.63% |
|
|||||
Total Common Equity | -57.48% | -23.93% | -28.61% | -21.24% | 29.43% |
Total Preferred Equity | -0.23% | -2.20% | 0.00% | -3.08% | -48.63% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -29.21% | -14.55% | -18.55% | -15.69% | -11.63% |
|